Weekly low-dose docetaxel in the treatment of lung metastases from angiosarcoma of the head [7]

British Journal of Dermatology

Volumn 152, Issue 4, 2005, Pages 811-812

  Yamada, M ^a   Hatta, N ^a   Mizuno, M ^a   Oishi, N ^a   Takehara, K ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DOCETAXEL; PACLITAXEL; PICIBANIL; RECOMBINANT INTERLEUKIN 2;

AGED; ANAPHYLAXIS; ANGIOSARCOMA; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; ELECTRON BEAM; FLUID RETENTION; HEAD AND NECK TUMOR; HEMATOTHORAX; HUMAN; LETTER; LUNG METASTASIS; MALE; NEUTROPENIA; PLEURA METASTASIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG ADMINISTRATION SCHEDULE; FATAL OUTCOME; HEAD AND NECK NEOPLASMS; HEMANGIOSARCOMA; HUMANS; LUNG NEOPLASMS; MALE; TAXOIDS;

EID: 17644427346     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06503.x     Document Type: Letter

References (10)

1. Mark RJ, Tran LM, Sercarz J et al. Angiosarcoma of the head and neck. The UCLA experience 1955 through 1990. Arch Otolaryngol Head Neck Surg 1993; 119:973-8.
2. Fakih MG, Defrances MC, Ohori NP, Ramanathan RK. Unusual tumors involving the head and neck region: case 1. Angiosarcoma of the scalp. J Clin Oncol 2001; 19:4173-4.
3. Eiling S, Lischner S, Bursch JO et al. Complete remission of a radio-resistant cutaneous angiosarcoma of the scalp by systemic treatment with liposomal doxorubicin. Br J Dermatol 2002; 147: 150-3.
4. Wollina U, Fuller J, Graefe T et al. Angiosarcoma of the scalp: treatment with liposomal doxorubicin and radiotherapy. J Cancer Res Clin Oncol 2001; 127:396-9.
5. Miura H, Inui S, Sakai H et al. Angiosarcoma of the scalp treated with OK-432 and rIL-2. Int J Dermatol 2002; 41:286-8.
6. Vasey PA. Role of docetaxel in the treatment of newly diagnosed advanced ovarian cancer. J Clin Oncol 2003; 21:136-44.
7. Hainsworth JD, Burris HA, Greco FA. Weekly administration of docetaxel: summary of clinical data. Semin Oncol 1999; 26:19-24.
8. Piccart MJ, Kilijn J, Paridaens R et al. Corticosteroids significantly delay the onset of docetaxel-induced fluid retention: final results of a randomised study of the European Organization for Research and Treatment of Cancer investigational drug branch for breast cancer. J Clin Oncol 1997; 15:3149-55.
9. Colevas AD, Posner MR. Docetaxel in head and neck cancer. Am J Clin Oncol 1998; 21:482-6.
10. Fata F, O'Reilly E, Ilson D et al. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer 1999; 86:2034-7.